Showing results (901-910 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|September 23, 2018
Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly MenJustin G Trogdon, Aaron D Falchook, Ramsankar Basak, et al.JAMA Oncology|September 30, 2018
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical TrialErminia Massarelli, William William, Faye Johnson, et al.JAMA Oncology|September 30, 2018
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort StudyJonggi Choi, Hyo Jeong Kim, Jayoun Lee, et al.JAMA Oncology|September 8, 2018
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent ChemotherapyRoberto Ferrara, Laura Mezquita, Matthieu Texier, et al.JAMA Oncology|March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)Kenneth L Kehl, David Zahrieh, Ping Yang, et al.JAMA Oncology|August 12, 2018
Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysisFrancesca Gay, Graham Jackson, Laura Rosiñol, et al.JAMA Oncology|September 5, 2018
Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical TrialVaibhav Sahai, Paul J Catalano, Mark M Zalupski, et al.JAMA Oncology|May 26, 2018
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.JAMA Oncology|May 26, 2018
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical TrialsJeremy M O'Connor, Kristen L Fessele, Jean Steiner, et al.JAMA Oncology|May 26, 2018
Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric CancerSheraz R Markar, Tom Wiggins, Stefan Antonowicz, et al.Pageof 161